{"Symbol": "MDWD", "AssetType": "Common Stock", "Name": "MediWound Ltd", "Description": "MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "42 Hayarkon Street, Yavne, Israel, 8122745", "FullTimeEmployees": "74", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "97687848", "EBITDA": "8181000", "PERatio": "27.0714", "PEGRatio": "-0.07", "BookValue": "0.372", "DividendPerShare": "None", "DividendYield": "0", "EPS": "0.243", "RevenuePerShareTTM": "0.7", "ProfitMargin": "-0.4834", "OperatingMarginTTM": "-0.5043", "ReturnOnAssetsTTM": "-0.1421", "ReturnOnEquityTTM": "-0.8511", "RevenueTTM": "19047000", "GrossProfitTTM": "19940000", "DilutedEPSTTM": "-0.339", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.806", "AnalystTargetPrice": "7.3", "TrailingPE": "27.0714", "ForwardPE": "0", "PriceToSalesRatioTTM": "5.3823", "PriceToBookRatio": "10.1249", "EVToRevenue": "4.2038", "EVToEBITDA": "15.3471", "Beta": "1.6275", "52WeekHigh": "4.34", "52WeekLow": "1.4427", "50DayMovingAverage": "3.7354", "200DayMovingAverage": "2.6114", "SharesOutstanding": "27211100", "SharesFloat": "17121242", "SharesShort": "41948", "SharesShortPriorMonth": "32929", "ShortRatio": "0.74", "ShortPercentOutstanding": "0", "ShortPercentFloat": "0.0062", "PercentInsiders": "41.955", "PercentInstitutions": "25.642", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}